Matthew Vincent Dolan Dexcom Inc (DXCM) insider trading activity

Matthew Vincent Dolan is EVP, Strategy & Corporate Dev of DEXCOM INC. Currently has a direct ownership of 42,044 shares of DXCM, which is worth approximately $3.68 Million. The most recent transaction as insider was on Jan 29, 2025, when has been sold 1,183 shares (Common Stock) at a price of $86.91 per share, resulting in proceeds of $102,814. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42K

4.91% 3M change

25.25% 12M change

Total Value Held $3.68 Million

Matthew Vincent Dolan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2025	SELL Open market or private sale	$102,814 $86.91 p/Share	1,183 Reduced 2.74%	42,044 Common Stock
Jan 28 2025	BUY Grant, award, or other acquisition	-	3,048 Added 6.59%	43,227 Common Stock
May 15 2024	SELL Open market or private sale	$306,703 $126.58 p/Share	2,423 Reduced 5.7%	40,075 Common Stock
Apr 15 2024	SELL Open market or private sale	$274,241 $137.81 p/Share	1,990 Reduced 4.49%	42,377 Common Stock
Mar 15 2024	SELL Open market or private sale	$548,281 $130.45 p/Share	4,203 Reduced 8.65%	44,367 Common Stock
Mar 12 2024	SELL Open market or private sale	$901,891 $134.41 p/Share	6,710 Reduced 12.14%	48,570 Common Stock
Mar 08 2024	BUY Grant, award, or other acquisition	-	21,711 Added 28.2%	55,280 Common Stock
Sep 01 2023	SELL Open market or private sale	$5,729 $102.32 p/Share	56 Reduced 0.17%	33,569 Common Stock
Mar 16 2023	SELL Open market or private sale	$264,845 $115.0 p/Share	2,303 Reduced 6.42%	33,569 Common Stock
Mar 13 2023	SELL Open market or private sale	$661,955 $106.27 p/Share	6,229 Reduced 14.8%	35,872 Common Stock
Mar 10 2023	SELL Sale (or disposition) back to the issuer	$691,125 $111.4 p/Share	6,204 Reduced 12.84%	42,101 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	21,769 Added 31.07%	48,305 Common Stock
Mar 06 2023	SELL Open market or private sale	$25,854 $114.4 p/Share	226 Reduced 0.84%	26,536 Common Stock
Sep 01 2022	SELL Open market or private sale	$408 $81.63 p/Share	5 Reduced 0.02%	26,536 Common Stock
Mar 17 2022	SELL Open market or private sale	$217,800 $450.0 p/Share	484 Reduced 6.8%	6,634 Common Stock
Mar 16 2022	SELL Open market or private sale	$291,550 $425.0 p/Share	686 Reduced 8.79%	7,118 Common Stock
Mar 15 2022	SELL Open market or private sale	$419,009 $412.41 p/Share	1,016 Reduced 11.52%	7,804 Common Stock
Mar 09 2022	SELL Sale (or disposition) back to the issuer	$655,787 $406.06 p/Share	1,615 Reduced 15.48%	8,820 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	2,889 Added 21.68%	10,435 Common Stock

MVD

Matthew Vincent Dolan

EVP, Strategy & Corporate Dev

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Value

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

Operation

Value

Type

News

Receive news related to DEXCOM INC

Track Activities on DXCM

Account